C5a promotes migration, proliferation, and vessel formation in endothelial cells

por Kurihara, Ryuji, Yamaoka, Kunihiro, Sawamukai, Norifumi, Shimajiri, Shohei, Oshita, Koichi, Yukawa, Sonosuke, Tokunaga, Mikiko, Iwata, Shigeru, Saito, Kazuyoshi, Chiba, Kenji, Tanaka, Yoshiya
Publicado 2010

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observation...

por Hirata, Shintaro, Saito, Kazuyoshi, Kubo, Satoshi, Fukuyo, Shunsuke, Mizuno, Yasushi, Iwata, Shigeru, Nawata, Masao, Sawamukai, Norifumi, Nakano, Kazuhisa, Yamaoka, Kunihiro, Tanaka, Yoshiya
Publicado 2013

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

por Tanaka, Yoshiya, Hirata, Shintaro, Kubo, Satoshi, Fukuyo, Shunsuke, Hanami, Kentaro, Sawamukai, Norifumi, Nakano, Kazuhisa, Nakayamada, Shingo, Yamaoka, Kunihiro, Sawamura, Fusae, Saito, Kazuyoshi
Publicado 2015